Track topics on Twitter Track topics that are important to you
EL SEGUNDO, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Griffin Capital Corporation ("Griffin Capital") on behalf of Griffin Institutional Access Real Estate Fund (Nasdaq:GIREX) announced today that GIREX has exceeded $100 million in assets under management since its launch in June 2014.
Randy I. Anderson, Portfolio Manager of GIREX said, "We are pleased with the growth of GIREX. Our ability to reach this asset milestone in a short period of time demonstrates the value advisors see in our investment strategy – that provides individual investors access to a portfolio of both public and private real estate securities diversified by sector, geography and manager."
To learn more about GIREX, go to http://www.griffincapital.com/griffin-institutional-access-real-estate-fund.
About Griffin Institutional Access Real Estate Fund and Griffin Capital Corporation
Griffin Institutional Access Real Estate Fund (Nasdaq:GIREX), a closed-end, interval fund registered under the Investment Company Act of 1940, is an actively-managed portfolio of private real estate funds and public real estate securities offering daily pricing and periodic liquidity at net asset value. GIREX began reporting on NASDAQ on June 30, 2014 with an initial share price of $25.00 and reported a share price of $26.03 as of June 1, 2015. The advisor of GIREX is Griffin Capital Advisor, LLC, a majority owned subsidiary of Griffin Capital Corporation. Griffin Capital Corporation a privately-owned real estate company headquartered in Los Angeles. Led by senior executives with more than two decades of real estate experience collectively encompassing over $20 billion of transaction value and more than 650 transactions, Griffin Capital and its affiliates have acquired or constructed approximately 36 million square feet of space since 1995. Griffin Capital and its affiliates manage, sponsor and/or co-sponsor a portfolio consisting of approximately 21 million square feet of space, located in 27 states, representing approximately $3.5 billion in asset value. Additional information about Griffin Capital is available at www.griffincapital.com.
Investors should carefully consider the investment objectives, risks, charges and expenses of the Griffin Institutional Access Real Estate Fund ("GIREX" or the "Fund"). This and other important information about the Fund is contained in the prospectus, which can be obtained by contacting your financial advisor or visiting www.griffincapital.com. The prospectus should be read carefully before investing.
Griffin Institutional Access Real Estate Fund Risk Considerations
As of 3/31/15 the fund has returned 8.04%. The GIREX inception date was 6/30/2014. GIREX gross expense ratio is 6.8%. Performance data quoted represents past performance. Past performance is no guarantee of future results and investment returns and principal value of the Fund will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than performance data quoted. The maximum sales charge is 5.75%. Purchases of $1,000,001 or more may be subject to a contingent deferred sales charge on shares redeemed during the first 365 days after their purchase. GIREX has contractually agreed to waive its fees to the extent that they exceed 1.91% until June 30, 2016. Without the waiver the expenses would have been higher. The NAV fund return does not reflect the deduction of all fees and if the fund return reflected the deduction of such fees, the performance would be lower. Visit www.griffincapital.com for current performance.
GIREX will not invest in real estate directly, but, because the Fund will concentrate its investments in securities of REITs and other real estate industry issuers, its portfolio will be significantly impacted by the performance of the real estate market and may experience more volatility and be exposed to greater risk than a more diversified portfolio. The value of companies engaged in the real estate industry is affected by: (i) changes in general economic and market conditions; (ii) changes in the value of real estate properties; (iii) risks related to local economic conditions, overbuilding and increased competition; (iv) increases in property taxes and operating expenses; (v) changes in zoning laws; (vi) casualty and condemnation losses; (vii) variations in rental income, neighborhood values or the appeal of property to tenants; (viii) the availability of financing and (ix) changes in interest rates and leverage.
Investors in GIREX should understand that the NAV of GIREX will fluctuate, which may result in a loss of the principal amount invested. GIREX is new with limited operating history. GIREX is a closed-end interval fund that provides liquidity to shareholders quarterly between five percent and 25 percent of its outstanding shares at net asset value. All or a portion of the distribution may be comprised of a return of capital.
Opinions expressed are current opinions as of the date appearing in this material only. No part of this material may, without the prior written consent of Griffin Capital, be (i) copied, photocopied or duplicated in any form, by any means, or (ii) distributed to any person that is not an employee, officer, director, or authorized agent of the recipient.
GIREX is distributed by ALPS Distributors, Inc. ALPS Distributors, Inc. is not affiliated with either Griffin Capital or any of its affiliates.
CONTACT: Jennifer Nahas Vice President, Marketing Griffin Capital Corporation email@example.com 949-270-9332NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...